Always putting healthier
lives first
News
-
Integrated Report 2024 has been releasedOpens in a new window.
-
Sawai Group Reports Financial Results for the first half of FY2024
-
Sawai Group Reports Financial Results for the first three months of FY2024
-
Medium-term Business Plan, "Beyond 2027" (PDF: 4.8MB)PDF opens
-
Sawai Group Reports FY2023 Financial Results
-
Sawai Receives Approvals for Six Generic Drugs with 11 StrengthsOpens in a new window.
-
Sawai Announces Listing of Two Generic Drugs with Three StrengthsOpens in a new window.
-
Sawai Receives Approvals for Three Generic Drugs with Four StrengthsOpens in a new window.
-
Notice of Transfer (Sale of Shares/Equity Interests) of Sawai’s U.S. Subsidiary / Sub-subsidiary (PDF: 390KB)PDF opens
-
Sawai Announces Listing of a single Generic Drug with Two StrengthsOpens in a new window.
Company Information
